Narula Sanjeev
Reporting owner on Forms 3, 4 and 5, CIK 1820590.
Narula Sanjeev reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-08.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| PHAT · Phathom Pharmaceuticals, Inc.CIK 1783183 | officer (Chief Financial & Bus. Officer) | 1 | 2026-10-08 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| PHAT · Phathom Pharmaceuticals, In…Common Stock | 2026-10-06 | F withheld for tax | -13,485 | $6.78 | 214,718 | Form 4 |
| PHAT · Phathom Pharmaceuticals, In…Common Stock, holding | 1,123 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-418114 | Phathom Pharmaceuticals, Inc. | 2026-10-08 |